Towards Healthcare
Veterinary CRO and CDMO Market Hits USD 7.77 Bn by 2025

Veterinary CRO and CDMO Market 2025 Asia-Pacific Leads Fastest Growth, North America Dominates Share

Market insights predict, the veterinary CRO and CDMO industry is expected to grow from USD 7.17 billion in 2024 to USD 16.13 billion by 2034, driven by a CAGR of 8.43%. The market is growing due to rising pet ownership and increased focus on animal health. Pharma companies are outsourcing R&D and manufacturing to reduce costs and speed up product development.

Content

  • Insight Code: 5873
  • No. of Pages: 150+
  • Format: PDF/PPT/Excel
  • Published: July 2025
  • Report Covered: [Revenue + Volume]
  • Historical Year: 2021-2022
  • Base Year: 2023
  • Estimated Years: 2024-2033

About The Author

Shivani Zoting is a dedicated research analyst specializing in the healthcare industry. With a strong academic foundation, a B.Sc. in Biotechnology and an MBA in Pharmabiotechnology, she brings a unique blend of scientific understanding and market strategy to her research.

Shivani contributes to Towards Healthcare and plays an active role at Precedence Research, where she focuses on delivering in-depth market intelligence, competitive analysis, and trend forecasting across pharmaceuticals, medical devices, digital health, and healthcare services. Her insights support healthcare companies, investors, and policymakers in making data-backed decisions in a highly regulated and rapidly evolving sector.

Additionally, Shivani collaborates with Statifacts, further expanding her healthcare domain reach by engaging in diverse projects across global markets. Her strength lies in transforming complex clinical and commercial data into strategic narratives that help stakeholders navigate the future of healthcare.

Talk to us
FAQ's

What is the forecast for the Veterinary CRO and CDMO Market from 2024 to 2034?

North America is currently leading the healthcare veterinary CRO and CDMO market due to its well-established animal healthcare infrastructure, high pet ownership rates, and strong presence of major pharmaceutical and biotech companies.

The veterinary CRO and CDMO market includes six segments by product type, by service type, by animal type, by development stage, by end use, and by region.

Some key players include Argenta, Aurigon Life Science, Avacta Animal Health, Biovet, Charles River Laboratories, etc. 

Key trends include the growth due to rising pet ownership and increased focus on animal health.

They provide services such as preclinical and clinical trials, regulatory affairs, drug formulation, process development, commercial manufacturing, and packaging.

India Brand Equity Foundation, Food and Drug Administration, U.S. Environmental Protection Agency, European Medicines Agency, and National Medical Products Administration.
Any Questions